Yessica Zamudio-Cuevas
Instituto Politécnico Nacional
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yessica Zamudio-Cuevas.
Clinical Rheumatology | 2015
Yessica Zamudio-Cuevas; Cristina Hernández-Díaz; Carlos Pineda; Anthony M. Reginato; Jorge F. Cerna-Cortes; Lucio Ventura-Ríos; Alberto López-Reyes
Gout is a disorder of urate metabolism in which persistent high urate levels in the extracellular fluids result in the deposition of monosodium urate (MSU) crystal in joints and periarticular tissues. In recent years, this disease represents an increasingly common health problem, so the pace of investigation in the field has accelerated tremendously. New research advances in the pathogenesis of hyperuricemia and in the understanding of how MSU crystals induce an acute gouty attack have been focused in this review on the processes of inflammation and involvement of the innate immune response; in addition, we discuss new knowledge about the role of the reactive oxygen species in establishing oxidative stress in MSU crystal-induced arthritis.
Oxidative Medicine and Cellular Longevity | 2016
Denise Clavijo-Cornejo; Karina Martínez-Flores; Karina Silva-Luna; Gabriela Angélica Martínez-Nava; Javier Fernández-Torres; Yessica Zamudio-Cuevas; Mónica Guadalupe Santamaría-Olmedo; Julio Granados-Montiel; Carlos Pineda; Alberto López-Reyes
Osteoarthritis is characterized by the presence of proinflammatory cytokines and reactive oxygen species. We aimed to clarify the role of prooxidant enzyme content at the synovial membrane level and how it correlates with the inflammatory process in patients with knee osteoarthritis (KOA). In synovial membranes from KOA patients and control group, we analyzed the protein content of prooxidant enzymes such as Nox2, xanthine oxidase (XO), and prolidase as well as the proinflammatory NALP3. Results show that protein content of prolidase and Nox2 increased 4.8- and 8.4-fold, respectively, and XO showed an increasing trend, while the NALP3 inflammasome increased 5.4-fold with respect to control group. Levels of prolidase and XO had a positive correlation between the levels of NALP3 and Nox2. By principal component analysis the protein expression pattern by study groups was evaluated. Three clusters were identified; protein expression patterns were higher for clusters two (prolidase) and three (XO and Nox2) between KOA patients and controls. Data suggest that prooxidant enzymes increase in synovial membrane of KOA patients and may contribute to the inflammatory state and degradation of the articular cartilage.
Journal of the Science of Food and Agriculture | 2018
Francesca Oliviero; Anna Scanu; Yessica Zamudio-Cuevas; Leonardo Punzi; Paolo Spinella
Polyphenols have been extensively investigated with regard to their antioxidant, anti-inflammatory, and immunomodulant properties in many inflammatory chronic conditions. The aim of this review is to summarise how these compounds can modulate the inflammatory pathways which characterise the most prevalent arthropathies including osteoarthritis, rheumatoid arthritis and crystal-induced arthritis. Among polyphenols, epigallocatechin gallate, carnosol, hydroxytyrosol, curcumin, resveratrol, kaempferol and genistein have been the most widely investigated in arthritis. The most important results of the studies outlined in this article show how polyphenolic compounds are able to inhibit the expression and the release of a number of pro-inflammatory mediators and proteolytic enzymes, the activity of different transcriptional factors and the production of reactive oxygen species in vitro. Studies on animal models of rheumatoid arthritis, osteoarthritis and gout show interesting results in terms of reduced tissue damage, restored cartilage homeostasis, and decreased levels of uric acid, respectively. Despite the multiple protective effects of polyphenols, there are no dietary recommendations for patients affected by rheumatic diseases. Future studies, including intervention trials, should be conducted to determine the relevance of polyphenols consumption or supplementation in arthritis.
Molecular Biology Reports | 2018
Javier Fernández-Torres; Yessica Zamudio-Cuevas; Alberto López-Reyes; Daniela Garrido-Rodríguez; Karina Martínez-Flores; Carlos A. Lozada; José Francisco Muñoz-Valle; Gabriela Angélica Martínez-Nava
This study was designed to investigate whether genetic polymorphisms of the Wnt/β-catenin signaling pathway and its interactions are involved in the development of knee osteoarthritis (KOA). Patients with KOA (n = 131) and healthy individuals (n = 190) with different ancestry from two Mexican populations (Mexico City and Guadalajara City) were analyzed. Twenty-five SNPs from thirteen genes (WISP1, DKK1, SOST, FRZB, LRP1, LRP4, LRP5, LRP6, GSKB, ADAMTS5, GDF5, FMN2 and COL11A1) involved in the Wnt/β-catenin signaling pathway were genotyped. Genetic and allelic frequencies and gene–gene interactions were performed for this study. After adjusting for age, sex, BMI and admixture, significant associations were found for five SNPs in Mexico City: LRP6 rs12314259 (G/G genotype OR 0.22, P = 0.029; and G allele OR 0.48, P = 0.022), SOST rs851054 (C/T genotype OR 0.42, P = 0.027; and T allele OR 0.62, P = 0.026), FMN2 rs986690 (G/A genotype OR 0.42, P = 0.034; and A allele OR 0.50, P = 0.015), FRZB rs409238 (A/G genotype, OR 2.41, P = 0.022), and COL11A1 rs2615977 (A/C genotype OR 2.39, P = 0.024); no associations for Guadalajara City were found. With respect to gene–gene interactions, the pairwise interactions of WISP1–COL11A1, COL11A1–FRZB, FRZB–SOST and WISP1–FMN2 make it possible to visualize the synergistic or antagonistic effect of their genotypes or alleles in both populations. These results suggest that gene–gene interactions in the Wnt/β-catenin signaling pathway play a role in the etiology of KOA.
International Immunopharmacology | 2018
Yessica Zamudio-Cuevas; Javier Fernández-Torres; Gabriela Angélica Martínez-Nava; Karina Martínez-Flores; Alberto López-Reyes
&NA; The anti‐inflammatory and immunomodulatory effects of nanoparticles in several chronic diseases have been extensively researched. The aim of this review is to examine how nanoparticles modulate the inflammatory pathways that characterize the most prevalent forms of microcrystal‐induced arthritis, including gout, pseudogout, and BCP‐induced arthritis. The nanoparticles of chitosan‐coated calcium phosphate, uricase, aceclofenac, and gold have been investigated in crystal‐inducedarthritis. The most important results of the studies outlined in this review show that nanoparticles can inhibit the expression and the release of some pro‐inflammatory mediators and proteolytic enzymes, and the activity of different transcriptional factors in vitro, as well as decrease the uric acid levels in several studies of in vitro and in vivo models of gout, which show interesting results in terms of decreasing the amount of crystals and tissue damage, respectively. In view of their multiple beneficial effects, nanoparticles can be considered a valuable therapy that contributes to the pharmacological treatment in crystalinduced arthritis. HighlightsNPs modulate the inflammatory pathways of crystal‐induced arthritis.NPs could inhibit the expression of several pro‐inflammatory mediators and proteolytic enzymes in crystal‐induced arthritis.NPs could induce activity of different transcriptional factors, as well as decrease uric acid levels.NPs alleviate inflammatory responses, decreasing the amount of crystals and tissue damage in gout and pseudogout.NPs can be considered a valuable therapy that contributes to the pharmacological treatment in crystal‐induced arthritis.
Connective Tissue Research | 2018
Javier Fernández-Torres; Gabriela Angélica Martínez-Nava; Francesca Oliviero; Alberto López-Reyes; Karina Martínez-Flores; Daniela Garrido-Rodríguez; Adriana Francisco-Balderas; Yessica Zamudio-Cuevas
ABSTRACT Background: The presence of genetic variants in uric acid (UA) transporters can be associated with hyperuricemia, and therefore with an increased risk of monosodium urate (MSU) crystal precipitation. The inflammatory process triggered by these crystals leads to cartilage damage, which, in turn, could promote knee osteoarthritis (KOA). Objective: To determine whether genetic polymorphisms of the UA transporters and their interactions are associated with KOA. Materials and Methods: Two hundred forty-three unrelated Mexican-mestizo individuals were recruited for this case-control study. Ninety-three of them were KOA patients but without gout, and one hundred and fifty healthy individuals with no symptoms or signs of KOA were recruited as controls. Forty-one single-nucleotide polymorphisms (SNPs) involved in the UA transporters were genotyped with OpenArray technology in a QuantStudio 12K flex-System with both cases and controls. Results: After adjusting by age, gender, BMI, and ancestry, significant associations were found for eight SNPs: rs1260326 (GCKR), rs780093 (GCKR), rs17050272 (INHBB), rs1471633 (PDZK1), rs12129861 (PDZK1), rs7193778 (IGF1R), rs17786744 (STC1), and rs1106766 (R3HDM2). With respect to gene–gene interactions, the pairwise interactions of rs112129861 (PDZK1) and rs7193778 (IGF1R); rs17050272 (INHBB) and rs1106766 (R3HDM2); rs1106766 (R3HDM2) and rs780093 (GCKR); rs1260326 (GCKR) and rs17786744 (STC1); and rs17786744 (STC1) and rs1106766 (R3HDM2) make it possible to visualize the synergistic or antagonistic effect of their genotypes or alleles on KOA development. Conclusions: Our preliminary results show that the common gene variants related to UA transport are associated with KOA in the Mexican population. Further studies must be carried out to corroborate it.
Oxidative Medicine and Cellular Longevity | 2017
Denise Clavijo-Cornejo; Karina Martínez-Flores; Karina Silva-Luna; Gabriela Angélica Martínez-Nava; Javier Fernández-Torres; Yessica Zamudio-Cuevas; Mónica Guadalupe Santamaría-Olmedo; Julio Granados-Montiel; Carlos Pineda; Alberto López-Reyes
[This corrects the article DOI: 10.1155/2016/1472567.].
BMC Musculoskeletal Disorders | 2015
Javier Fernández-Torres; Cristina Hernández-Díaz; Rolando Espinosa-Morales; Javier Camacho-Galindo; Norma del Carmen Galindo-Sevilla; Ambar López-Macay; Yessica Zamudio-Cuevas; Karina Martínez-Flores; Mónica Guadalupe Santamaría-Olmedo; Carlos Pineda; Julio Granados; Gabriela Angélica Martínez-Nava; Marwin Gutierrez; Alberto López-Reyes
Arthritis Research & Therapy | 2015
Carlos Pineda; Arturo Javier Fuentes-Gómez; Cristina Hernández-Díaz; Yessica Zamudio-Cuevas; Javier Fernández-Torres; Ambar López-Macay; Ismael Alba-Sánchez; Javier Camacho-Galindo; Lucio Ventura; Luis Enrique Gómez-Quiroz; María Concepción Gutiérrez-Ruiz; Francisco García-Vázquez; Anthony M. Reginato; Marwin Gutierrez; Alberto López-Reyes
Arthritis Research & Therapy | 2016
Yessica Zamudio-Cuevas; Karina Martínez-Flores; Javier Fernández-Torres; Yahir A. Loissell-Baltazar; Daniel Medina-Luna; Ambar López-Macay; Javier Camacho-Galindo; Cristina Hernández-Díaz; Mónica Guadalupe Santamaría-Olmedo; Edgar Oliver López-Villegas; Francesca Oliviero; Anna Scanu; Jorge F. Cerna-Cortes; Marwin Gutierrez; Carlos Pineda; Alberto López-Reyes